Title : Trastuzumab With S-1 Plus Cisplatin in HER2-positive Advanced Gastric Cancer Without Measurable Lesions: OGSG 1202.

Pub. Date : 2019 Feb

PMID : 30711995






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Trastuzumab With S-1 Plus Cisplatin in HER2-positive Advanced Gastric Cancer Without Measurable Lesions: OGSG 1202. Cisplatin erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 BACKGROUND/AIM: Trastuzumab with S-1 plus cisplatin was proved to be effective for human epidermal growth factor receptor type 2 (HER2)-positive advanced gastric cancer with measurable lesions. Cisplatin erb-b2 receptor tyrosine kinase 2 Homo sapiens
3 CONCLUSION: Trastuzumab with S-1 plus cisplatin might be effective and tolerable for HER2-positive advanced gastric cancer without measurable lesions. Cisplatin erb-b2 receptor tyrosine kinase 2 Homo sapiens